Implantation of the HeartMate 3 in Subjects with | Clinical Research Studies Listing

Implantation of the HeartMate 3 in Subjects with Heart Failure

Recruiting

18 years - 99 years

All

Phase N/A

150 participants needed

1 Location

Brief description of study

This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Heart Failure,Heart Diseases,Cardiovascular Diseases
Age: 18 years - 99 years
Gender: All

Subject must be ≥ 18 years of age Subject is receiving the HM3 as their first LVAD

Updated on 04 Aug 2024. Study ID: 844962

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Implantation of the HeartMate 3 in Subjects with Heart Failure

Brief description of study

Eligibility of study

Find a site

Interested in the study